|
Market Cap (19-May) $522,816,704 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (5-May) 2,410,503 (2.97%) (86th) |
|
52w High $7.31 |
52w Low $3.74 |
P/E 285.71 |
EPS -1.56 |
MYX released this announcement to the ASX on 1 February 2022, 15:13. The announcement is not marked as price sensitive, and is 5 page(s) in length and 498.72kb in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 2.201% short sold according to ASIC data. It was ranked the 92nd most shorted stock on the ASX. It is now ranked as the 86th most shorted stock on the ASX with 2.967% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| Ceasing to be a substantial holder | 1 February 2022, 15:13 |
| Initial Director's Interest Notice | 1 February 2022, 10:19 |
| Non-Executive Director appointment and retirement | 17 January 2022, 8:37 |
| Mayne Pharma adds a generic PROTOPIC to US portfolio | 12 January 2022, 8:21 |
You must be logged in to post a reply.
Mayne Pharma Group 